Skip to main content
Technology

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Feed excerpt — reported by TechCrunch

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at TechCrunch →

Original Source

This article was syndicated from TechCrunch. All rights remain with the original publisher.